Given that tumors in recurrent endometrial cancer patients tend to display greater malignancy and likely require increased WEE1 for DNA repair, we investigated WEE1 expression in tumor tissues from recurrent and non-recurrent endometrial cancer patients. Here, WEE1 is linked to neoplasm.